EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

Konw More

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

In The News

Indian Pharma Exports Reach USD 29 Billion in FY26: Generics and Global Demand Drive Growth - Indian Pharma Exports Reach USD 29 Billion in FY26: Generics and Global Demand Drive Growth India’s pharmaceutical export sector continues its strong upward trajectory, clocking approximately USD 29 billion in exports by the end of February in FY2025-26, according to data released by the Pharmaceuticals Export Promotion Council of India (Pharmexcil). This represents sustained growth […]
Indian Pharma Exports Surge 18% in Q1 FY2026-27: US ANDA Approvals & Africa Demand Drive Growth - India’s pharmaceutical export sector has recorded an impressive 18% growth in the first quarter of fiscal year 2026-27 (April–June 2026), driven by a surge in US ANDA (Abbreviated New Drug Application) approvals and robust demand from African markets, according to industry data released by Pharmexcil and leading financial analysts. Quarterly Performance Highlights The Q1 FY27 […]
Indian Generic Pharma Exports Surge 14% in Q1 2026 as New PLI Scheme Targets 25 Additional API Molecules - The Indian pharmaceutical export sector has registered a robust 14% year-on-year growth in the first quarter of calendar 2026, reaching USD 8.4 billion, according to the latest data released by the Pharmaceuticals Export Promotion Council of India (Pharmexcil). This growth marks a significant rebound for the industry, driven primarily by surging demand for anti-diabetic and […]
Pirfenidone for Post-COVID Pulmonary Fibrosis: 2025–2026 Latest Research & Real Result - New Findings in Pulmonary Fibrosis and Post-COVID Lung Disease Pulmonary fibrosis after COVID-19 is leaving thousands of patients struggling to breathe every day. Many are desperately searching for treatments that can actually slow or stop lung scarring.Pirfenidone, one of the most widely used antifibrotic drugs, has been in the spotlight again with new 2025–2026 research. […]
Read More

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

Stay Connected

If you have any question,please connect us.

Connect Us

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Join Us